DK1576187T3 - Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer - Google Patents

Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer

Info

Publication number
DK1576187T3
DK1576187T3 DK03785912T DK03785912T DK1576187T3 DK 1576187 T3 DK1576187 T3 DK 1576187T3 DK 03785912 T DK03785912 T DK 03785912T DK 03785912 T DK03785912 T DK 03785912T DK 1576187 T3 DK1576187 T3 DK 1576187T3
Authority
DK
Denmark
Prior art keywords
cancer
plasma
determining
detection
amount
Prior art date
Application number
DK03785912T
Other languages
English (en)
Inventor
Gabriella Sozzi
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Application granted granted Critical
Publication of DK1576187T3 publication Critical patent/DK1576187T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6818Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK03785912T 2002-12-23 2003-12-22 Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer DK1576187T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002743A ITMI20022743A1 (it) 2002-12-23 2002-12-23 Metodo per la determinazione del rischio di comparsa, della presenza o del decorso di malattie tumorali.
PCT/EP2003/014719 WO2004057024A1 (en) 2002-12-23 2003-12-22 Method for the detection of cancer

Publications (1)

Publication Number Publication Date
DK1576187T3 true DK1576187T3 (da) 2010-01-11

Family

ID=32676859

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03785912T DK1576187T3 (da) 2002-12-23 2003-12-22 Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer

Country Status (9)

Country Link
US (1) US7888008B2 (da)
EP (1) EP1576187B1 (da)
AT (1) ATE442456T1 (da)
AU (1) AU2003294932A1 (da)
DE (1) DE60329224D1 (da)
DK (1) DK1576187T3 (da)
ES (1) ES2332716T3 (da)
IT (1) ITMI20022743A1 (da)
WO (1) WO2004057024A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712639B1 (en) * 2005-04-06 2008-08-27 Maurice Stroun Method for the diagnosis of cancer by detecting circulating DNA and RNA
CN104593505A (zh) * 2015-01-23 2015-05-06 上海迪安医学检验所有限公司 一种检测全血或血清样品中端粒酶的活性程度的试剂盒
JP7239973B2 (ja) * 2017-12-19 2023-03-15 国立大学法人山口大学 前癌病変又は癌の有無の予測を補助する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2324997A (en) * 1996-03-15 1997-10-01 Penn State Research Foundation, The Detection of extracellular tumor-associated nucleic acid in blood plasma or ser um using nucleic acid amplification assays
US6475789B1 (en) * 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
AU2682299A (en) 1998-02-16 1999-08-30 University Of Maryland At Baltimore Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis
US7160996B1 (en) * 1999-06-09 2007-01-09 Bioresearch Technologies, Inc. Fluorescence energy transfer probes with stabilized conformations
US6664046B1 (en) * 1999-12-16 2003-12-16 Roche Molecular Systems, Inc. Quantitation of hTERT mRNA expression
EP1158055A1 (fr) * 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Méthode pour le diagnostic de cancers

Also Published As

Publication number Publication date
ITMI20022743A1 (it) 2004-06-24
EP1576187B1 (en) 2009-09-09
ATE442456T1 (de) 2009-09-15
DE60329224D1 (de) 2009-10-22
EP1576187A1 (en) 2005-09-21
US7888008B2 (en) 2011-02-15
US20070148644A1 (en) 2007-06-28
ES2332716T3 (es) 2010-02-11
WO2004057024A1 (en) 2004-07-08
AU2003294932A1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
Hourigan et al. Measurable residual disease testing in acute myeloid leukaemia
DK1071710T4 (da) Genomisk sekvens for 5-lipoxygenase-aktiveringsproteinet (FLAP), polymorfe markører deri og fremgangsmåder til påvisning af astma
DK1342794T3 (da) Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
GB0712154D0 (en) Method for evaluating correlations between structured and normalized information on genetic variations between humans and their personal clinical patient data
WO2008041953A3 (en) Dengue diagnosis and treatment
DK2848938T3 (da) Evaluering af effektiviteten af en behandling hos et individ baseret på st2- niveauer
WO2002086663A3 (en) Computer system fro providing information about the risk of an atypical clinical event based upon genetic information
WO2004030511A3 (en) Prostate cancer biomarkers
EP2293209A3 (en) Method and apparatus for detecting and predicting biological anomalies and cerebral disorders
WO2008140463A3 (en) Biomarker panels for assessing radiation injury and exposure
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
Sterling et al. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir
ATE555430T1 (de) Systeme und verfahren für computersicherheit
Chen et al. The relationship between the methylated septin‐9 DNA blood test and stool occult blood test for diagnosing colorectal cancer in Taiwanese people
WO2012010871A3 (en) Systems and methods for medical data processing and analysis
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
FR2894046B1 (fr) Procede de detection d'une erreur d'entree d'un des parametres de decollage dans un systeme de management de vol
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
WO2006015874A8 (en) Method for diagnosing liver fibrosis
WO2007103211A3 (en) Methods to identify fat and lean animals using class predictors
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
TW200613734A (en) Detection and identification of peptide and protein modifications
DK1576187T3 (da) Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer
CY1111970T1 (el) Μεθοδοι για την ανιχνευση της νοσου αλτσχαϊμερ
RU2012133434A (ru) Способы и наборы для детекции факторов риска развития остеонекроза челюсти и способы его лечения